Skip to main content
SpringerLink
Log in

Gastric Cancer Worldwide Except Japan

  • Chapter
  • First Online:
Gastric Cancer

Abstract

Until recently, gastric cancer was the most common cause of cancer deaths. Despite the rapid fall in incidence, gastric cancer is still the fifth most common cancer and third leading cause of cancer-related mortality worldwide. The lifetime risk of gastric cancer to age 74 remains between 1 and 3% in most European countries and as high as 5–20% in some parts of Asia. The discovery of Helicobacter pylori as the cause of atrophic gastritis, the lesion that predisposes to gastric cancer, has resulted in increasing attempts to eliminate gastric cancer by eradicating H. pylori. Here we review the worldwide changes in gastric cancer incidence and the current lifetime risk.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hoffman FL. The mortality from cancer throughout the world. Newark: Prudential Press; 1915.

    Google Scholar 

  2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43–66.

    Article  Google Scholar 

  3. Rielgel F. Carcinoma of the stomach. In: Stockton CG, editor. Diseases of the stomach in Nothnagel’s encyclopedia of practice of medicine. Nothnagel’s practice. Philadelphia: W.B. Saunders & Company; 1903. p. 644.

    Google Scholar 

  4. Williams WR. The increase of cancer, and its concomitants. In: Williams WR, editor. The natural history of cancer. New York: William Wood and Company; 1908. p. 55.

    Google Scholar 

  5. Haberlin H. Uber verbreitung und aetiologie des magenkrebses. Ueber neue diagnostische Humsmittel beim magenhkrebs. Arch F Klin, Med; Xlv. 1889.

    Google Scholar 

  6. Faber K. Chronic gastritis: its relation to achylia and ulcer. Lancet. 1927;2:902–7.

    Google Scholar 

  7. Faber K. Gastritis and its consequences. Paris: Oxford University Press; 1935.

    Google Scholar 

  8. Graham DY, Asaka M. Eradication of gastric cancer and more efficient gastric cancer surveillance in Japan: two peas in a pod. J Gastroenterol. 2010;45:1–8.

    Article  Google Scholar 

  9. Hurst AF. Schorstein lecture on the precursors of carcinoma of the stomach. Lancet. 1929;214:1023–8.

    Article  Google Scholar 

  10. Bockus HL. Carcinoma of the stomach. In: Bockus HL, editor. Gastroenterology, vol. 1. Philadelphia: W.B. Saunders Co.; 1963. p. 748.

    Google Scholar 

  11. von den Velden R. Ueber vorkommen und mandgel der freien salzsaure in magensaft bei gastrektasie. Deutsches Arch F Klin Med. 1879;23:369–99.

    Google Scholar 

  12. Comfort MW, Vanzant FR. Gastric acidity in carcinoma of the stomach. Am J Surg. 1934;26:447–56.

    Article  Google Scholar 

  13. Comfort MW. Gastric acidity before and after development of gastric cancer: its etiologic, diagnostic and prognostic significance. Ann Intern Med. 1951;36:1331–48.

    Google Scholar 

  14. Kikuchi S, Nakajima T, Kobayashi O, et al. Effect of age on the relationship between gastric cancer and Helicobacter pylori. Tokyo Research Group of Prevention for Gastric Cancer. Jpn J Cancer Res. 2000;91:774–9.

    Article  CAS  Google Scholar 

  15. Masci E, Viale E, Freschi M, et al. Precancerous gastric lesions and Helicobacter pylori. Hepatogastroenterology. 1996;43:854–8.

    CAS  PubMed  Google Scholar 

  16. Urita Y, Hike K, Torii N, et al. Serum pepsinogens as a predicator of the topography of intestinal metaplasia in patients with atrophic gastritis. Dig Dis Sci. 2004;49:795–801.

    Article  CAS  Google Scholar 

  17. Graham DY. Helicobacter pylori infection is the primary cause of gastric cancer. J Gastroenterol. 2000;35(Suppl 12):90–7.

    PubMed  Google Scholar 

  18. Graham DY. History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer. World J Gastroenterol. 2014;20:5191–204.

    Article  Google Scholar 

  19. Graham DY, Shiotani A. The time to eradicate gastric cancer is now. Gut. 2005;54:735–8.

    Article  CAS  Google Scholar 

  20. Wang C, Weber A, Graham DY. Age, period, and cohort effects on gastric cancer mortality. Dig Dis Sci. 2015;60:514–23.

    Article  Google Scholar 

  21. Correa P, Haenszel W, Cuello C, et al. A model for gastric cancer epidemiology. Lancet. 1975;2:58–60.

    Article  CAS  Google Scholar 

  22. Correa P, Cuello C, Duque E, et al. Gastric cancer in Colombia. III. Natural history of precursor lesions. J Natl Cancer Inst. 1976;57:1027–35.

    Article  CAS  Google Scholar 

  23. El-Zimaity HM, Ota H, Graham DY, et al. Patterns of gastric atrophy in intestinal type gastric carcinoma. Cancer. 2002;94:1428–36.

    Article  Google Scholar 

  24. Graham DY, Kato M, Asaka M. Gastric endoscopy in the 21st century: appropriate use of an invasive procedure in the era of non-invasive testing. Dig Liver Dis. 2008;40:497–503.

    Article  CAS  Google Scholar 

  25. Schmidt PH, Lee JR, Joshi V, et al. Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma. Lab Invest. 1999;79:639–46.

    CAS  PubMed  Google Scholar 

  26. Graham DY. Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits. Gastroenterology. 2015;148:719–31.

    Article  Google Scholar 

  27. Miftahussurur M, Yamaoka Y, Graham DY. Helicobacter pylori as an oncogenic pathogen, revisited. Expert Rev Mol Med. 2017;19:e4.

    Article  Google Scholar 

  28. Correa P, Piazuelo MB, Wilson KT. Pathology of gastric intestinal metaplasia: clinical implications. Am J Gastroenterol. 2010;105:493–8.

    Article  Google Scholar 

  29. El-Zimaity HMT, Gutierrez O, Kim JG, et al. Geographic differences in the distribution of intestinal metaplasia in duodenal ulcer patients. Am J Gastroenterol. 2001;96:666–72.

    Article  Google Scholar 

  30. Capelle LG, de Vries AC, Haringsma J, et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc. 2010;71:1150–8.

    Article  Google Scholar 

  31. Rugge M, Meggio A, Pennelli G, et al. Gastritis staging in clinical practice: the OLGA staging system. Gut. 2007;56:631–6.

    Article  Google Scholar 

  32. Song H, Ekheden IG, Zheng Z, et al. Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population. BMJ. 2015;351:h3867.

    Article  Google Scholar 

  33. Li D, Bautista MC, Jiang SF, et al. Risks and predictors of gastric adenocarcinoma in patients with gastric intestinal metaplasia and dysplasia: a population-based study. Am J Gastroenterol. 2016;111:1104–13.

    Article  Google Scholar 

  34. Reddy KM, Chang JI, Shi JM, et al. Risk of gastric cancer among patients with intestinal metaplasia of the stomach in a US Integrated Health Care System. Clin Gastroenterol Hepatol. 2016;14:1420–5.

    Article  Google Scholar 

  35. Ferlay JSI, Soerjomatarm I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide; IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013.

    Google Scholar 

  36. Tsugane S, Akabane M, Inami T, et al. Urinary salt excretion and stomach cancer mortality among four Japanese populations. Cancer Causes Control. 1991;2:165–8.

    Article  CAS  Google Scholar 

  37. Kamada T, Haruma K, Ito M, et al. Time trends in Helicobacter pylori infection and atrophic gastritis over 40 years in Japan. Helicobacter. 2015;20:192–8.

    Article  Google Scholar 

  38. Lee YC, Chiang TH, Chou CK, et al. Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis. Gastroenterology. 2016;150:1113–24.

    Article  Google Scholar 

  39. Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents, Vol. IX. IARC Sci Publ. 2007;160:1–837.

    Google Scholar 

  40. Forman D, Bray F, Brewster DH, et al. Cancer incidence in five continents, Vol. X. IARC Sci Publ. 2014;164:1–1365.

    Google Scholar 

  41. Parkin DM, Whelan SL, Ferlay J, et al. Cancer incidence in five continents, Vol. VIII. IARC Sci Publ. 2002;155:1–781.

    Google Scholar 

  42. Lee YC, Chiang TH, Liou JM, et al. Mass Eradication of Helicobacter pylori to prevent gastric cancer: theoretical and practical considerations. Gut Liver. 2016;10:12–26.

    Article  Google Scholar 

Download references

Acknowledgments

Support: Dr. Graham is supported in part by the Office of Research and Development Medical Research Service Department of Veterans Affairs, Public Health Service grant DK56338 which funds the Texas Medical Center Digestive Diseases Center.

Disclosures: Dr. Graham is a consultant for RedHill Biopharma regarding novel H. pylori therapies and has received research support for culture of Helicobacter pylori and is the PI of an international study of the use of antimycobacterial therapy for Crohn’s disease. He is also a consultant for BioGaia in relation to probiotic therapy for H. pylori infection and for Takeda in relation to H. pylori therapies. Drs. Tan and Balakrishnan do not have any relevant disclosures.

Author information

Authors and Affiliations

  1. Department of Medicine, Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, TX, USA

    Mimi C. Tan, Maya Balakrishnan & David Y. Graham

Authors
  1. Mimi C. Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maya Balakrishnan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David Y. Graham
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David Y. Graham .

Editor information

Editors and Affiliations

  1. Department of Internal Medicine, Kawasaki Medical School Kurashiki, Okayama, Japan

    Akiko Shiotani

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Tan, M.C., Balakrishnan, M., Graham, D.Y. (2019). Gastric Cancer Worldwide Except Japan. In: Shiotani, A. (eds) Gastric Cancer. Springer, Singapore. https://doi.org/10.1007/978-981-13-1120-8_2

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-1120-8_2

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-1119-2

  • Online ISBN: 978-981-13-1120-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation